[The use of extracorporeal blood purification for the treatment of cardiac rhythm disorders].
Hemosorption and plasmapheresis were used in 26 patients with episodes of atrial fibrillation and extrasystoles. A response lasting 4 +/- 0.9 months was registered in 80% of cases. Negative effects were absent.
Nedostup
A V
AV
Panasiuk
V V
VV
Boldyrev
D A
DA
Kalugina
G V
GV
Ivanov
M I
MI
Komiagin
Iu V
IuV
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000097:blood / Q000628:therapy*; D005117:Cardiac Complexes, Premature / Q000097:blood / Q000628:therapy*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D005260:Female; D006464:Hemoperfusion / Q000009:adverse effects / Q000295:instrumentation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis / Q000009:adverse effects / Q000295:instrumentation
D000889:Anti-Arrhythmia Agents